Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Selecting appropriate first line lung cancer therapy

AACR 2009

18 - 22 Apr 2009

Published: 8 Jul 2009

Views: 15791

Rating:

Save

Dr Paul Bunn - University of Colorado, Denver, USA

erlotininb, cetuximab or gefitinib for lung cancer in pill form- less toxic and better tolerated, better survival for patients with EGFR gene mutation.

Related Videos

The role of multidisciplinary tumour board in managing stage 3 lung cancer

Prof Walter Weder - Privatklinik Bethanien, Zürich, Switzerland

The role of multidisciplinary tumour board in managing stage 3 lung cancer ( Prof Walter Weder - Privatklinik Bethanien, Zürich, Switzerland )

ESMO 2022: Lung roundup

Dr Luis Raez - Memorial Cancer Institute, Miami, USA

ESMO 2022: Lung roundup ( Dr Luis Raez - Memorial Cancer Institute, Miami, USA )

From clinic to practice in NSCLC patients with exon 20 mutations

Prof Nicolas Girard - Institut Curie, Paris, France

From clinic to practice in NSCLC patients with exon 20 mutations ( Prof Nicolas Girard - Institut Curie, Paris, France )

Pembrolizumab plus chemo shows prolonged OS and PFS improvement vs chemo for...

Dr Silvia Novello - University of Turin, Turin, Italy

Pembrolizumab plus chemo shows prolonged OS and PFS improvement vs chemo for squamous NSCLC ( Dr Silvia Novello - University of Turin, Turin, Italy )

Scientists discover mechanism of action and an actionable inflammatory axis for...

Prof Charles Swanton - The Francis Crick Institute, London, UK

Scientists discover mechanism of action and an actionable inflammatory axis for air pollution induced NSCLC ( Prof Charles Swanton - The Francis Crick Institute, London, UK )

WCLC 2022: Highlights

Dr Luis Raez - Memorial Cancer Institute, Florida, USA

WCLC 2022: Highlights ( Dr Luis Raez - Memorial Cancer Institute, Florida, USA )

OncoAlert and ecancer weekly round up for August 8th - 14th, 2022

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly round up for August 8th - 14th, 2022 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

What's new in molecular targeted treatments for EGFR mutant NSCLC

Dr Keith Kerr, Dr Melina Marmarelis, Prof Amanda Tufman and Dr Jordi Remón Masip

What's new in molecular targeted treatments for EGFR mutant NSCLC ( Dr Keith Kerr, Dr Melina Marmarelis, Prof Amanda Tufman and Dr Jordi Remón Masip )

Topics under discussion at the WCLC 2022 presidential symposium

Dr Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain

Topics under discussion at the WCLC 2022 presidential symposium ( Dr Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain )

More from ecancer